The Provigil Vigil

After the Plavix debacle, the Federal Trade Commission, and investors, are wondering about Cephalon's lifeblood Provigil. Cephalon says there's nothing to worry about.

Is there another Plavix out there? That was the question on everyones’ mind as they watched Bristol-Myers Squibb’s settlement with Apotex unravel with devastating speed. (See "The War on Generics – Part I," in this issue. [A#])

Speculation among investors immediately focused on Cephalon Inc. and its settlements with the four companies who first challenged a...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Legal & IP

More from Pink Sheet